sur Rentschler Biopharma SE
Rentschler Biopharma Promotes Patrick Meyer to Global Head of Business Development
Rentschler Biopharma SE, a prominent contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced Patrick Meyer, Ph.D., as the new Global Head of Business Development. With immediate effect, Dr. Meyer will lead the business development team and shape the company's global commercial strategy. He joins the Executive Committee, reporting directly to CEO Benedikt von Braunmühl.
Dr. Meyer, with over eight years at Rentschler, recently served as Global Head BD Sales and Alliance Management. His extensive experience in managing key accounts and strategic partnerships prepares him for this role. He aims to develop solutions focused on client challenges, creating meaningful impacts through innovative biopharmaceuticals.
Rentschler Biopharma demonstrates a commitment to internal talent development, highlighting its strategic focus on value creation and sustainable partnerships in the biopharmaceutical sector.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Rentschler Biopharma SE